740 related articles for article (PubMed ID: 27214046)
1. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J
Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial.
Kaeley GS; Evangelisto AM; Nishio MJ; Goss SL; Liu S; Kalabic J; Kupper H
J Rheumatol; 2016 Aug; 43(8):1480-9. PubMed ID: 27307526
[TBL] [Abstract][Full Text] [Related]
3. Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.
Kaeley GS; MacCarter DK; Pangan AL; Wang X; Kalabic J; Ranganath VK
J Rheumatol; 2018 Dec; 45(12):1628-1635. PubMed ID: 30173153
[TBL] [Abstract][Full Text] [Related]
4. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908
[TBL] [Abstract][Full Text] [Related]
5. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
6. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
7. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
8. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis.
Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Satoh K; Tamai M; Nakamura H; Okada A; Koga T; Yamasaki S; Ida H; Origuchi T; Eguchi K
Rheumatology (Oxford); 2011 May; 50(5):962-5. PubMed ID: 21186172
[TBL] [Abstract][Full Text] [Related]
9. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420
[TBL] [Abstract][Full Text] [Related]
10. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound joint inflammation in rheumatoid arthritis in clinical remission: how many and which joints should be assessed?
Naredo E; Valor L; De la Torre I; Martínez-Barrio J; Hinojosa M; Aramburu F; Ovalles-Bonilla JG; Hernández D; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L
Arthritis Care Res (Hoboken); 2013 Apr; 65(4):512-7. PubMed ID: 23044729
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A
Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842
[TBL] [Abstract][Full Text] [Related]
13. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
[TBL] [Abstract][Full Text] [Related]
14. Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids.
Larché MJ; Seymour M; Lim A; Eckersley RJ; Pétavy F; Chiesa F; Rioja I; Lukey PT; Binks M; McClinton C; Dolan K; Taylor PC
J Rheumatol; 2010 Dec; 37(12):2493-501. PubMed ID: 20889600
[TBL] [Abstract][Full Text] [Related]
15. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
Finzel S; Kraus S; Figueiredo CP; Regensburger A; Kocijan R; Rech J; Schett G
Ann Rheum Dis; 2019 Sep; 78(9):1186-1191. PubMed ID: 31142474
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
[TBL] [Abstract][Full Text] [Related]
18. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH
J Rheumatol; 2009 Jul; 36(7):1429-41. PubMed ID: 19369462
[TBL] [Abstract][Full Text] [Related]
19. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
[TBL] [Abstract][Full Text] [Related]
20. Intra-articular methotrexate versus corticosteroid injections in medium-sized joints of rheumatoid arthritis patients-an intervention study.
Mortada MA; Abdelwhab SM; Elgawish MH
Clin Rheumatol; 2018 Feb; 37(2):331-337. PubMed ID: 28963634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]